90 studies found for:    Open Studies | "Mesothelioma"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Mesothelioma" (90 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Not yet recruiting Pembrolizumab in Treating Patients With Malignant Mesothelioma
Conditions: Biphasic Mesothelioma;   Epithelioid Mesothelioma;   Peritoneal Malignant Mesothelioma;   Pleural Biphasic Mesothelioma;   Pleural Epithelioid Mesothelioma;   Pleural Malignant Mesothelioma;   Pleural Sarcomatoid Mesothelioma;   Recurrent Peritoneal Malignant Mesothelioma;   Recurrent Pleural Malignant Mesothelioma;   Sarcomatoid Mesothelioma
Interventions: Biological: Pembrolizumab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacogenomic Study
2 Recruiting Intrapleural Measles Virus Therapy in Patients With Malignant Pleural Mesothelioma
Conditions: Recurrent Malignant Mesothelioma;   Stage IA Malignant Mesothelioma;   Stage IB Malignant Mesothelioma;   Stage II Malignant Mesothelioma;   Stage III Malignant Mesothelioma;   Stage IV Malignant Mesothelioma
Interventions: Biological: oncolytic measles virus encoding thyroidal sodium iodide symporter;   Other: laboratory biomarker analysis;   Procedure: single photon emission computed tomography;   Procedure: computed tomography
3 Recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
Conditions: Advanced Malignant Mesothelioma;   Epithelioid Mesothelioma;   Recurrent Malignant Mesothelioma;   Sarcomatoid Mesothelioma
Interventions: Drug: Cediranib Maleate;   Drug: Cisplatin;   Drug: Pemetrexed Disodium;   Other: Placebo
4 Not yet recruiting Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma
Conditions: Advanced Pleural Malignant Mesothelioma;   HLA-A*0201 Positive Cells Present;   Recurrent Non-Small Cell Lung Carcinoma;   Recurrent Pleural Malignant Mesothelioma;   Stage III Pleural Mesothelioma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer;   Stage IV Pleural Mesothelioma
Interventions: Biological: Autologous WT1-TCRc4 Gene-transduced CD8-positive Tcm/Tn Lymphocytes;   Drug: Cyclophosphamide;   Biological: Aldesleukin;   Procedure: Therapeutic Conventional Surgery;   Other: Laboratory Biomarker Analysis
5 Not yet recruiting Alisertib in Malignant Mesothelioma
Conditions: Lung Cancer;   Mesothelioma
Intervention: Drug: Alisertib
6 Recruiting Do Your Genes Put You at a Higher Risk of Developing Mesothelioma
Condition: Mesothelioma
Intervention:
7 Recruiting Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Condition: Mesothelioma
Intervention:
8 Unknown  Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Condition: Mesothelioma
Intervention: Drug: Velcade (bortezomib) plus Eloxatin (oxaliplatin)
9 Not yet recruiting Vinorelbine in Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Vinorelbine;   Other: Active Symptom Control
10 Recruiting Pemetrexed Disodium or Observation in Treating Patients With Malignant Pleural Mesothelioma Without Progressive Disease After First-Line Chemotherapy
Condition: Malignant Mesothelioma
Interventions: Drug: pemetrexed disodium;   Other: clinical observation
11 Unknown  Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
Conditions: Lung Cancer;   Mesothelioma
Intervention:
12 Not yet recruiting Screening of Alberta Asbestos Exposed Workers for Lung Cancer and Mesothelioma
Conditions: Lung Cancer;   Mesothelioma
Interventions: Procedure: Low-dose computed tomography Annual scan x3;   Procedure: Low-dose computed tomography Baseline scan only
13 Unknown  Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to Asbestos
Conditions: Mesothelioma;   Lung Cancer
Intervention:
14 Recruiting SS1P and Pentostatin Plus Cyclophosphamide for Mesothelioma
Condition: Mesothelioma
Interventions: Drug: Pentostatin;   Drug: Cyclophosphamide;   Biological: SS1(dsFv)PE38
15 Recruiting Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
Condition: Mesothelioma
Intervention: Drug: Zometa (zoledronic acid)
16 Not yet recruiting Safety and Efficacy of Oshadi D and Oshadi R for Malignant Mesothelioma Treatment
Condition: Mesothelioma
Intervention: Drug: Oshadi D and Oshadi R
17 Recruiting PIT: Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma
Condition: Mesothelioma
Intervention: Radiation: Prophylactic Irradiation of Tracts (PIT)
18 Unknown  Axitinib in Malignant Mesothelioma
Condition: Malignant Pleural Mesothelioma
Interventions: Biological: axitinib;   Drug: chemotherapy
19 Unknown  The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
Condition: Malignant Mesothelioma
Intervention: Drug: Tremelimumab
20 Not yet recruiting Study of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM).
Condition: Mesothelioma, Malignant
Interventions: Drug: Placebo;   Drug: Amatuximab;   Drug: Pemetrexed;   Drug: Cisplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years